Mammalian Fertilization: Identifying the second sperm factor that induces residual calcium oscillations and its contributions to egg activation

哺乳动物受精:识别诱导残留钙振荡的第二个精子因子及其对卵子激活的贡献

基本信息

项目摘要

There is a persistent gap in our knowledge of the sperm molecules and mechanisms that induce Ca2+ oscillations in mammalian eggs. Ca2+ release triggers egg activation and initiation of embryo development in all mammals, including human beings. A sperm molecule, the sperm factor, SF, later identified as Phospholipase zeta, PLCz, was thought to be the only SF responsible for inducing Ca2+ release, and PLCz inactivating mutations cause infertility in human males. However, Plcz knockout mice are subfertile and evoke residual Ca2+ oscillations, suggesting the function of a backup mechanism. The component(s) and the physiological role of the backup system are gaps in our knowledge. These gaps represent serious impediments, as until we overcome them, we do not understand the Ca2+ regulation of egg activation events or can objectively diagnose, prevent or treat infertility associated with egg activation failure. The long-term goal is to understand the molecular basis of the Ca2+ oscillations that unfold the developmental program at fertilization. The objective is to identify the sperm molecules that trigger these Ca2+ oscillations in the egg. The mouse and its gametes are perfect models because they are amenable to manipulation and genetic modifications. The central hypothesis underpinning this proposal is that one or more sperm PLCs besides PLCz contribute to delivering the Ca2+ signal and could serve as the backup mechanism in case of Plcz disfunction. This hypothesis was conceived based on extensive preliminary data. The rationale for the proposed research is that once all sperm molecules that induce oscillations are known, their regulation assessed, and their diagnostic value and application to the reproductive management of species fully explored. We plan to test our central hypothesis by pursuing the following specific aims: 1) Identify the molecule(s) in PLC1z-KO sperm that induce Ca2+ oscillations at fertilization; 2) Determine the contribution of the backup system to the Ca2+ responses and egg activation events of typical fertilization. Under Aim 1, we will use Trim-21 mRNA, specific antibodies, CRISPR-generated KO mouse lines, immunofluorescence, Ca2+ monitoring, and embryo culture to determine if PLCd4 is the active factor of the backup system. Under Aim 2, we will employ similar methods but target different molecules and mechanisms to ascertain the contribution of the Ca2+ backup system to the Ca2+ signal of typical fertilization. The research in this application is innovative because it represents a fresh examination of the role of other sperm PLCs, including one whose deletion causes male infertility, in the oscillations of fertilization. The contributions of the proposed project are significant because we aim to perfect the treatment of egg activation failure, improve embryo development, discover indicators of male fertility, and identify novel targets of contraception. Finally, we anticipate progress in understanding the molecules and regulatory mechanisms that induce embryo development in mammals.
我们对诱导Ca2+的精子分子和机制的知识存在持续的差距 哺乳动物卵中的振荡。 CA2+释放触发卵的激活和胚胎发育的启动 在包括人类在内的所有哺乳动物中。精子分子(精子因子)SF,后来被确定为 磷脂酶Zeta,PLCZ被认为是唯一负责诱导Ca2+释放的SF,并且 PLCZ灭活突变会导致人类男性不孕。但是,PLCZ淘汰小鼠是属的 并引起残留的Ca2+振荡,这表明了备用机制的功能。组件 备份系统的生理作用是我们所知的差距。这些差距代表严重 障碍,因为在我们克服它们之前,我们不了解卵子激活的Ca2+调节 事件或可以客观地诊断,预防或治疗与卵激活失败相关的不育症。这 长期目标是了解展开发育的Ca2+振荡的分子基础 受精的计划。目的是识别触发这些CA2+振荡的精子分子 在鸡蛋中。鼠标及其配子是完美的模型,因为它们可以操纵 和遗传修饰。该提议的基础的中心假设是一个或多个精子 PLC除了PLCZ外,有助于传递CA2+信号,并且可以用作备份机构 如果有PLCZ失功。该假设是基于广泛的初步数据来构想的。这 拟议研究的理由是,一旦所有诱导振荡的精子分子都知道, 他们的监管评估,以及对诊断价值以及对生殖管理的应用 物种全面探索。我们计划通过追求以下特定目的来检验中心假设:1) 识别PLC1Z-KO精子中诱导Ca2+振荡时的分子; 2)确定 备用系统对CA2+反应和典型施肥的卵激活事件的贡献。 在AIM 1下,我们将使用TRIM-21 mRNA,特定抗体,CRISPR生成的KO小鼠系, 免疫荧光,Ca2+监测和胚胎培养 备份系统。在AIM 2下,我们将采用类似的方法,但针对不同的分子和 确定Ca2+备份系统对CA2+信号的贡献的机制 受精。该应用中的研究具有创新性,因为它代表了对 其他精子plc的作用,包括删除会导致男性不育症的作用,在振荡中 受精。拟议项目的贡献很重要,因为我们旨在完善 治疗卵子激活衰竭,改善胚胎发育,发现男性生育率的指标以及 确定新颖的避孕目标。最后,我们预计了解分子的进展 以及诱导哺乳动物胚胎发育的调节机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rafael Antonio Fissore其他文献

Rafael Antonio Fissore的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Rafael Antonio Fissore', 18)}}的其他基金

Regulation of Ca2+ influx in mouse oocytes and eggs during maturation and fertilization to improve assisted reproductive technologies and modulate fertility
调节小鼠卵母细胞和卵在成熟和受精过程中的 Ca2 流入,以改进辅助生殖技术并调节生育力
  • 批准号:
    9766344
  • 财政年份:
    2018
  • 资助金额:
    $ 23.48万
  • 项目类别:
Regulation of Ca2+ influx in mouse oocytes and eggs during maturation and fertilization to improve assisted reproductive technologies and modulate fertility
调节小鼠卵母细胞和卵在成熟和受精过程中的 Ca2 流入,以改进辅助生殖技术并调节生育力
  • 批准号:
    10401470
  • 财政年份:
    2018
  • 资助金额:
    $ 23.48万
  • 项目类别:
Frontiers in Reproduction (FIR) Training Course
生殖前沿 (FIR) 培训课程
  • 批准号:
    10617172
  • 财政年份:
    2014
  • 资助金额:
    $ 23.48万
  • 项目类别:
IP3r-1 Regulation and Egg Activation
IP3r-1 调节和卵激活
  • 批准号:
    7618191
  • 财政年份:
    2007
  • 资助金额:
    $ 23.48万
  • 项目类别:
IP3r-1 Regulation and Egg Activation
IP3r-1 调节和卵激活
  • 批准号:
    7840470
  • 财政年份:
    2007
  • 资助金额:
    $ 23.48万
  • 项目类别:
IP3r-1 Regulation and Egg Activation
IP3r-1 调节和卵激活
  • 批准号:
    8069624
  • 财政年份:
    2007
  • 资助金额:
    $ 23.48万
  • 项目类别:
LP3R-1 Regulation and Egg Activation
LP3R-1 调节和卵子激活
  • 批准号:
    7260244
  • 财政年份:
    2007
  • 资助金额:
    $ 23.48万
  • 项目类别:
LP3R-1 Regulation and Egg Activation
LP3R-1 调节和卵子激活
  • 批准号:
    7417908
  • 财政年份:
    2007
  • 资助金额:
    $ 23.48万
  • 项目类别:
Release and molecular composition of mammalian SFs
哺乳动物 SF 的释放和分子组成
  • 批准号:
    6687127
  • 财政年份:
    2003
  • 资助金额:
    $ 23.48万
  • 项目类别:
Release and molecular composition of mammalian SFs
哺乳动物 SF 的释放和分子组成
  • 批准号:
    6772484
  • 财政年份:
    2003
  • 资助金额:
    $ 23.48万
  • 项目类别:

相似国自然基金

建立新型的基因编辑小鼠生物反应器广谱表达抗肠毒素B(SEB)单克隆抗体
  • 批准号:
    31900676
  • 批准年份:
    2019
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
TRAF6/mTOR双向调控巨噬细胞极化在放疗联合PD-1抗体诱导远隔效应中的作用及机制研究
  • 批准号:
    81903135
  • 批准年份:
    2019
  • 资助金额:
    20.5 万元
  • 项目类别:
    青年科学基金项目
TLR4调控系统性红斑狼疮中自身反应性B-1a细胞活化的作用及机理研究
  • 批准号:
    81901635
  • 批准年份:
    2019
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
超高效免疫磁MOFs纳米材料设计及其在动物源样品前处理中的应用研究
  • 批准号:
    31873026
  • 批准年份:
    2018
  • 资助金额:
    61.0 万元
  • 项目类别:
    面上项目
哺乳动物细胞抗体人工进化平台的研究
  • 批准号:
    31870923
  • 批准年份:
    2018
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目

相似海外基金

Mechanisms underlying diarrhea and gut inflammation mediated by Enterotoxigenic and Enteropathogenic E. coli
产肠毒素和致病性大肠杆菌介导的腹泻和肠道炎症的机制
  • 批准号:
    10674072
  • 财政年份:
    2023
  • 资助金额:
    $ 23.48万
  • 项目类别:
Novel first-in-class Therapeutics for Rheumatoid Arthritis
类风湿关节炎的一流新疗法
  • 批准号:
    10696749
  • 财政年份:
    2023
  • 资助金额:
    $ 23.48万
  • 项目类别:
The Role of Fat in Osteoarthritis
脂肪在骨关节炎中的作用
  • 批准号:
    10866687
  • 财政年份:
    2023
  • 资助金额:
    $ 23.48万
  • 项目类别:
Novel therapy for arthrofibrosis
关节纤维化的新疗法
  • 批准号:
    10759562
  • 财政年份:
    2023
  • 资助金额:
    $ 23.48万
  • 项目类别:
Establishment of a Bat Resource for Infectious Disease Research
建立用于传染病研究的蝙蝠资源
  • 批准号:
    10495114
  • 财政年份:
    2023
  • 资助金额:
    $ 23.48万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了